BOHLEN; Heribert

Patent Applications and Registrations

Patent applications and USPTO patent grants for BOHLEN; Heribert.The latest application filed is for "in vitro method for providing stem cell derived cardiomyocytes".

Company Profile

3.9.18

BOHLEN; Heribert - Koln DE
Bohlen; Heribert - Cologne DE
Bohlen, Heribert - K?ouml;ln DE
BOHLEN, HERIBERT - BRUSSELS BE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
In Vitro Method For Providing Stem Cell Derived Cardiomyocytes App 20210147805 - WOLTERS; Benjamin ; et al.	2021-05-20
Non-invasive, In Vitro Functional Tissue Assay Systems App 20210025869 - BOHLEN; HERIBERT ; et al.	2021-01-28
System And Method For Cell Type-specific Translation Of Rna Molecules In Eukaryotes App 20200063131 - Bohlen; Heribert ; et al.	2020-02-27
Non-invasive, In Vitro Functional Tissue Assay Systems App 20180299426 - BOHLEN; HERIBERT ; et al.	2018-10-18
Non-invasive, in vitro functional tissue assay systems Grant 9,945,840 - Bohlen , et al. April 17, 2	2018-04-17
Assay for drug discovery based on in vitro differentiated cells Grant 9,726,662 - Bohlen , et al. August 8, 2	2017-08-08
Tissue Modeling In Embryonic Stem (es) Cell System App 20170160259 - KOLOSSOV; EUGEN ; et al.	2017-06-08
Assay For Drug Discovery Based On In Vitro Differentiated Cells App 20160209399 - Bohlen; Heribert ; et al.	2016-07-21
Assay For Drug Discovery Based On In Vitro Differentiated Cells App 20160209400 - BOHLEN; HERIBERT ; et al.	2016-07-21
Assay For Drug Discovery Based On In Vitro Differentiated Cells App 20160209398 - BOHLEN; HERIBERT ; et al.	2016-07-21
Tissue modeling in embryonic stem (ES) cell system Grant 9,321,997 - Kolossov , et al. April 26, 2	2016-04-26
Immune modulating oligonucleotides in connection with chemotherapeutic measures Grant 9,212,366 - Wittig , et al. December 15, 2	2015-12-15
Assay For Drug Discovery Based On In Vitro Differentiated Cells App 20130102497 - Bohlen; Heribert ; et al.	2013-04-25
Assay for drug discovery based on in vitro differentiated cells Grant 8,318,488 - Bohlen , et al. November 27, 2	2012-11-27
Method for the preparation of embryoid bodies (EBs) and uses thereof Grant 8,148,152 - Kolossov , et al. April 3, 2	2012-04-03
Novel Treatment Of Heart Diseases App 20110081325 - Bohlen; Heribert	2011-04-07
System for the Cell-Specific and Development-Specific Selection of Differentiating Embryonic Stem Cells, Adult Stem Cells and Embryonic Germline Cells App 20110059456 - FLEISCHMANN; Bernd ; et al.	2011-03-10
Immune Modulating Oligonucleotides in Connection with Chemotherapeutic Measures App 20090053250 - Wittig; Burghardt ; et al.	2009-02-26
Non-Invasive, In Vitro Functional Tissue Assay Systems App 20080132422 - Bohlen; Heribert ; et al.	2008-06-05
Novel Method for the Preparation of Embryoid Bodies (Ebs) and Uses Thereof App 20080019952 - Kolossov; Eugen ; et al.	2008-01-24
Tissue Modeling in Embryonic Stem (Es) Cell System App 20070258948 - Kolossov; Eugen ; et al.	2007-11-08
System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells App 20040096432 - Fleischmann, Bernd ; et al.	2004-05-20
Idiotypic Vaccination Against B Cell Lymphoma App 20030072751 - BOHLEN, HERIBERT ; et al.	2003-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.